MannKind (MNKD)
(Delayed Data from NSDQ)
$4.65 USD
-0.09 (-1.80%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $4.62 -0.03 (-0.54%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Brokerage Reports
0 items in cart
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 121 - 140 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Initiating Coverage with a Market Outperform and a $12 price target.
Provider: BRINSON PATRICK SECURITIES CORPORATION
Analyst: JAMES C
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Management is laying the foundation for Afrezza?s debut.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
NDA will be submitted in mid-October, as planned.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
We reiterate our BUY recommendation and maintain our price target to $11.00.
Provider: Griffin Securities, Inc.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Research Coverage Under Reivew
Provider: BRINSON PATRICK SECURITIES CORPORATION